Related references
Note: Only part of the references are listed.Serotonin, food intake, and obesity
Katy A. van Galen et al.
OBESITY REVIEWS (2021)
Improvement in mood symptoms after post-bariatric surgery among people with obesity: A systematic review and meta-analysis
Huai Heng Loh et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Renal lipotoxicity: Insights from experimental models
Barbara Bruna Abreu Castro et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2021)
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay et al.
ANTIOXIDANTS (2020)
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
Patrycja Bielawiec et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Evaluation of antenatal risk factors for postpartum depression: a secondary cohort analysis of the cluster-randomised GeliS trial
Hamimatunnisa Johar et al.
BMC MEDICINE (2020)
Outcomes in Bariatric and Metabolic Surgery: an Updated 5-Year Review
A. E. Roth et al.
CURRENT OBESITY REPORTS (2020)
Depression and obesity: evidence of shared biological mechanisms
Yuri Milaneschi et al.
MOLECULAR PSYCHIATRY (2019)
Circulating Endocannabinoids Are Reduced Following Bariatric Surgery and Associated with Improved Metabolic Homeostasis in Humans
Shahar Azar et al.
OBESITY SURGERY (2019)
Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis
K. Vanessa Carias et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion
Maria Rosa Trentin Zorzenon et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
The 5-HT1A receptor: Signaling to behavior
Paul R. Albert et al.
BIOCHIMIE (2019)
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Ila M. Linares et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression
D. Hen-Shoval et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
The Global Epidemic of the Metabolic Syndrome
Mohammad G. Saklayen
CURRENT HYPERTENSION REPORTS (2018)
Obesity as a Disease
Jagriti Upadhyay et al.
MEDICAL CLINICS OF NORTH AMERICA (2018)
Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats
Roger G. Pertwee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
MECHANISMS IN ENDOCRINOLOGY Endocannabinoids and metabolism: past, present and future
Vincent Simon et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling
Joseph Tam et al.
MOLECULAR METABOLISM (2017)
Muscle dysfunction caused by loss of Magel2 in a mouse model of Prader-Willi and Schaaf-Yang syndromes
Ain A. Kamaludin et al.
HUMAN MOLECULAR GENETICS (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Cannabidiol promotes browning in 3T3-L1 adipocytes
Hilal Ahmad Parray et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016
Helene Huvenne et al.
OBESITY FACTS (2016)
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Pradere-Willi syndrome
Ibrahim Knani et al.
MOLECULAR METABOLISM (2016)
Modulatory Role of Postsynaptic 5-Hydroxytryptamine Type 1A Receptors in (±)-8-Hydroxy-N,N-dipropyl-2-aminotetralin-Induced Hyperphagia in Mice
Jan Brosda et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings
M. A. Angulo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol
Nina L. Cluny et al.
PLOS ONE (2015)
PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells
Thomas A. Lagace
CURRENT OPINION IN LIPIDOLOGY (2014)
Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Joseph Tam et al.
CELL METABOLISM (2012)
Prader-Willi syndrome
Suzanne B. Cassidy et al.
GENETICS IN MEDICINE (2012)
A guide to analysis of mouse energy metabolism
Matthias H. Tschoep et al.
NATURE METHODS (2012)
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors
Bogna Ignatowska-Jankowska et al.
NEUROSCIENCE LETTERS (2011)
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists
America A. Scopinho et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Prader-Willi Syndrome and Angelman Syndrome
Karin Buiting
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2010)
Overweight, Obesity, and Depression A Systematic Review and Meta-analysis of Longitudinal Studies
Floriana S. Luppino et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
High-fat diet-induced obesity in animal models
Niloofar Hariri et al.
NUTRITION RESEARCH REVIEWS (2010)
Regionally Reduced Brain Volume, Altered Serotonin Neurochemistry, and Abnormal Behavior in Mice Null for the Circadian Rhythm Output Gene Magel2
Rebecca E. Mercer et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Effect of Rimonabant on the High-Triglyceride/Low-HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat The ADAGIO-Lipids Trial
Jean-Pierre Despres et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes
M. Gallant et al.
PHYTOMEDICINE (2009)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome
Jocelyn M. Bischof et al.
HUMAN MOLECULAR GENETICS (2007)
8-hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors
I. S. Ebenezer et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2007)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Share Paper
